Sunday, July 18, 2010

Blood tests 2.0: finger-stick and microneedle array

The farther future could include smartpatches - non-invasive, invisible, continuously-worn health self-monitoring skin patches. In the nearer future, a killer app for synthetic biology and other new chemistry and biology 2.0 methods could be the ability to create one's own vitamin supplements, and possibly innovate low-cost, non-prescription based finger-stick blood tests, and saliva and urine panels for self-testing.

Barrier to Citizen Science
A significant barrier to the wide-scale adoption of citizen science in the context of health self-management, intervention exploration, and preventive medicine implementation is the high cost, inconvenience and discomfort involved in obtaining traditional lab tests. While many tests may be ordered in a direct-to-consumer fashion through DirectLabs, the Life Extension Foundation, and other websites, it still costs ~$100 per test.

The challenge is to identify the requisite chemistry and processes involved and see if it may be possible to make simple consumer-friendly finger-stick blood test cartridges, similar to the glucose and HDL measurement kits sold at drug stores, which self-experimenters may perform at home or at community biolabs. Continuous monitoring via microneedle arrays would be useful for self-tracking glucose levels and other markers. For example, there could be consumer-targeted versions of the devices being developed by Orsense.

Figure 1. Non-invasive glucose monitoring device from Orsense


Community labs and high-end home labs may include the (CLIA-waived) Cholestech LDX machine (~$2,000 for the machine + ~$5-10 per measurement cassette) which can assess eight different lipid profiles.

Figure 2. Cholestech LDX finger-stick lipid measurement device


There is an urgent opportunity to expand the range of finger-stick measurement tests. Below is a Wish List of basic tests for one-off or comprehensive panel delivery.

Traditional Blood markers:
  • Homocysteine
  • Vitamin B-12
  • Folate
  • Vitamin D
  • Creatinine
  • eGFR
  • Cortisol
  • Calcium
  • Iron
  • Aldosterone
Hormones
  • Estrogen
  • Progesterone
  • Testosterone
  • Estradiol

Sunday, July 11, 2010

Ethics of historical revivification

Thought experiment: Assuming a world or worlds without basic resource constraints, if technologically possible, would it be more humane or less human humane to revive dead persons from history? Even those recently dead could be out of sync with the current milieu. Obviously, there would need to be rehab programs as contemplated in science fiction, for example,

"Life 101: Introducing Genghis Khan to the iPhone"
If is arguable that some large percent of dead persons would find enjoyment and utility in revivification.

The interpretation of the core rights of the individual could be different in the future. “Life, liberty, and the pursuit of happiness” seems immutable, even when considered in the possible farther future context of many worlds, uploaded mindfiles, and human/AI hybrid intelligences. However, how these principles are applied in practice could seem strange from different historical viewpoints.

Attributes that might be important to an individual now, for example embodiment or corporeality (being physically instantiated in a body), could well be moot in the future. On-demand instantiation could be a norm to complement digital mindfiles.

It could be queried whether revived historical persons should have the option to re-die? Dying and suicide could be much different conceptually in a digital upload culture. Choosing not to run your mindfile could be legal, but deleting it (and all backups) could be the equivalent of suicide, which is generally illegal in contemporary society.

Sunday, July 04, 2010

Automated nourishment

An interesting question arose from discussions at the recent IFTF annual forecast presentation - Would people be more or less healthy in a possible future era of 3-D food-printing on-demand?

Both sides of the case can be seen. The immediate conclusion might be that if anyone could print any food item on-demand any time, people would over-consume and be less healthy.

However, one of the biggest mistakes that can occur when considering a potential future advance is thinking of it in isolation and not bringing forward all other aspects of technology and society to this point too. In an era with on-demand 3-D food printing, other changes are also likely to have occurred. The first and most obvious is that perhaps food content or accompanying supplements, drugs, and nutraceuticals have changed to mean that food that tastes good is not necessarily unhealthy, even when consumed in large quantities. Non-fat non-sugar substitutes may have become seamless matches in the quality of taste but not in caloric consumption. Today’s unhealthy foods could go the way of cigarettes. Automated calorie consumption data collection might finally be possible.

A second argument for why people would be more rather than less healthy in an era of on-demand 3-D food printing is the massively granular physical tracking and biofeedback tools that could exist for each person. Smarthouse and smartclothing data collection through scanning and air, toilet, and unnoticeable blood stick diagnostics could be inputs to a continuously updating personal digital health model (e.g.; the future analog to Entelos's virtual patient or Archimedes's virtual twin). A personal digital health model could be used to assess exactly which real-time nutritional adjustments are needed by an individual. An automated menu plan from the kitchen printer may be preferable for creating meals based on an individual’s known preferences and reactions together with real-time needs. The portable personal digital health model could be permissioned into restaurant settings to similarly allow for customized meal synthesis.

A third argument comes from considering the potential trajectories of social networking and behavior change research. Already peer social networks have a strong influence on individual behavior. One’s whole peer network or interest group could be encouraging healthy behavior via team-based support and/or competition. The advent and widespread adoption of self-tracking and social interaction tools could bring about a new sensibility and personal responsibility for health self-management. Optional financial incentives from insurance companies could further facilitate behavior change.

Conclusion
In any possible future, there could be different technologies and social behavioral norms influencing the process of human nourishment. Food could become healthier over time and unobtrusive self-tracking tools and financial incentives could shift people to automated menu plans. Healthier behavior could be triggered just by making it easy.

Sunday, June 27, 2010

Questions uplevel the web

A new internet trend has popped up – asking questions to friends and strangers. Questions are a light-weight means of bringing structure and context to social interaction.

Many people start off with a low level of engagement (e.g.; what is the best pizza place in your neighborhood?). Things can start scaling up (e.g.; how much does it cost for a family to live in London on average?) and become quite detailed (e.g.; can a publisher see the average CPC or eCPM of a particular ad or advertiser on AdSense?). More importantly, more complex thoughts, opinion, philosophy, and value systems are being elicited (e.g.; what is a good real-world example of the "prisoner's dilemma" in recent history?).

The question-asking trend began with Hunch asking users questions to draw a taste profile map for users. The current generation of the concept features sites like Quora and formspring where users ask each other questions. Users have profiles and friending/following capability, with their questions and answer activity appearing in a status feed. It is like a friend network with topic precision.

Metrics would be interesting, such as the level of semantic complexity of questions, the number of repeated questions (an indicator of what is on the collective mind), and the ratio of asked to answered questions.

Question networks could be the real start of the semantic web, the natural automated approach (akin to Google’s automated machine learning) for creating the next higher level of information density.

Sunday, June 20, 2010

Crisis telediagnosis mobile app demo

Technology-driven tools are evolving so that crisis response can be more participatory, and have more advance preparedness. A demo of the Triage4G mobile app (Android and web platforms) occurred at the Clear 4G WiMAX Developers Symposium held at Stanford University, June 15, 2010. The Triage4G app features live video-conferencing and real-time matching between first responders/crisis victims and remote physicians for telediagnosis. (Application download)

Figure 1. Crisis telediagnosis: real-time matching of first responders/victims and remote physicians for live streaming video telediagnosis


Figure 2. Screenshots - a first responder launches the Triage4G app and inputs Triage Tag data. GPS information is use to create case number. A real-time remote physician match is requested.

Figure 3. Screenshots - a physician receives SMS notification of a patient requesting telediagnosis and logs in to the Triage4G app via smartphone or desktop.

Figure 4. Screenshots - when the match is complete, the first responder's screen updates with the case number and a button to launch Qik. The doctor's screen updates to the first responder's Qik page and then the live video steam begins.

Sunday, June 13, 2010

Dollar Van Demos

Easily the phreshest idea from New York’s Internet Week, held in Manhattan June 7-14, was Dollar Van Demos! Dollar Van Demos are a showcase of musicians, rappers, and comedians performing inside a dollar van with real passengers. Numerous Brooklyn-based artists are featured in a collection of videos filmed inside dollar vans as they travel along their usual transportation routes.

The site has new videos from Cocoa Sarai, Tah Phrum Duh Bush, Grey Matter, Zuzuka Poderosa, Kid Lucky, Atlas, BIMB Family, I-John, Top Dolla Raz, Hasan Salaam, illSpokinn, Joya Bravo, Bacardiiiii and Jarel soon!

Figure 1. Example videos from Cocoa Sarai and Top $ Raz

Sunday, June 06, 2010

Rational growth in consumer genomics

The overall tone of the Consumer Genetics Show, held June 2-4, 2010 in Boston MA, was a pragmatic focus on the issues at hand as compared with the enthusiasm and optimism that had marked the conference’s inaugural event last year. One of the biggest shifts was the new programs that some top-tier health service providers have been developing to include genetic testing and interpretation in their organizations. It also became clear that the few widely-agreed upon success stories for genomics in disease diagnosis and drug response (i.e.; warfarin dosing) have been costly to achieve and will not scale to all diseases and all drugs. Cancer continues to be a key killer app for genomics in diagnosis, treatment, prognosis, cancer tumor sequencing, and risk prediction. Appropriate approaches to multigenic risk assessment for health risk and drug response remain untackled. Greater state and federal regulation seems inevitable. Faster-than-Moore’s-law improvements in sequencing costs continue as Illumina dropped the price of whole human genome sequencing for the retail market from $48,000 to $19,500.

There was generally wide agreement that from a public health perspective, personalized genomics is scientifically valid, clinically useful, and reimbursable in specific situations, but not universally – at this time, better information should be obtained for some people, not more information for all people. The focus should be on medical genetics strongly linked to disease, and on pharmacogenomics in treatment. For example, genomic analysis is required for some drugs by the FDA (maraviroc, cetuximab, trastuzumab, and dasatinib), and recommended for several others (warfarin, rasburicase, carbamazepine, abacavir, azathiprine, and irinotecan). A key point is to integrate the drug test with the guidance for drug dosage.

Even when genomic tests are inexpensive enough to be routine, interpretation may be a bottleneck as each individual’s situation is different when taking into account family history, personal medical history, and environmental and other factors. One idea was that the 20,000 pathologists in the US could be a resource for genomic test interpretation; pathologists are already involved as they must certify genetic test data in CLIA labs. Genomic tests and their interpretation would likely need to be standardized and certified in order to be reimbursed in routine medical care. A challenge is that health service payers are not interested or able to drive genomic test product design.

Key science findings

1. The Regulome and Structural Variation

Michael Snyder presented important research that the regulome, the parts of the genome located around the exome (the 1-2% of the genome that codes for protein), may be critical in understanding disease genesis and biological processes. The complexities of RNA are just beginning to be understood. It is known that there is more than just the simple transcription of DNA to RNA involved in controlling gene expression. For example, there is also tight regulation in splicing newly synthesized RNA molecules into the final RNA molecule and in translating messenger RNA to ribosomes to create proteins. Research findings indicate a global/local model of gene regulation, that there are master regulators with universal reach and local regulators operating on a local range of 200 or so genes.

Snyder also presented updates on his lab’s ongoing research into the structural variation of the human genome. A high-resolution sequencing study has been conducted regarding the amount of structural variation in humans, finding that there are ~1,500 structural variations per person that are over 3 kilobases long and that the majority of the structural variations are 3-10 kilobases long with a few extending to 50-100 kilobases (application of this research: Kasowski M, Science, 2010 Apr 9).

2. Reaching beyond the genome to the diseasome, proteome, and microbiome

Several scientists addressed the ways in which science is quickly reaching beyond the single point mutations and structural variation of the genome to other layers of information. There is a need for the digital quantification of the epigenome, the methylome, the transcriptome, the proteome, the metabolome, and the dieaseome/VDJome. For example, the immune system is one of the best monitors of disease state and progression. The strength of individual immune systems can be evaluated through the VDJome (the repertoire of recombined V-D-J regions in immune cells; cumulative immunoglobulin and T-cell receptor antigen exposure)

There are many areas of interest in proteomics including protein profiling, protein-protein interactions, and post-translational modification. A large-scale digital approach to proteomics was presented by Michael Weiner of Affomix. A key focal area is post-translational modification. At least one hundred post-translational modifications have been found, and two are being investigated in particular: phosphorylation (the signal transduction can possibly indicate tumor formation) and glycosylation (possibly indicating tumor progression).

The microbiome (human microbial bacteria) and host-bacteria interactions are an important area for understanding human disease and drug response, and for Procter & Gamble in creating consumer products. The company has basic research and publications underlying products such as the ProX anti-wrinkle skin cream (Hillebrand, Brit Jrl Derm, 2010), rhinovirus, and gingivitis. The company has a substantial vested interest in understanding the microbiome with its variety of nasal, oral, scalp, respiratory, skin, and GI tract-related products.

Sunday, May 30, 2010

Microbubbles and photoacoustic probes energize cancer researchers

The Canary Foundation’s eighth year of activities was marked with a symposium held at Stanford University May 25-27, 2010. The Canary Foundation focuses on the early detection of cancer, specifically lung, ovarian, pancreatic, and prostate cancer, in a three-step process of blood tests, imaging, and targeted treatment.

Imaging advances: microbubbles and photoacoustic probes
Imaging is an area that continues to make advances. One exciting development is the integration of multiple technologies, for example superimposing molecular information onto traditional CT scans. Contemporary scans may show that certain genes are over-expressed in the heart, for example, but obscure the specific nodule (tumor) location. Using integrins to bind to cancerous areas may allow their specific location to be detected (4 mm nodules now, and perhaps 2-3 mm nodules as scanning technologies continue to improve).

Other examples of integrated imaging technologies include microbubbles, which are gassy and can be detected with an ultrasound probe as they are triggered to vibrate. Similarly, photoacoustic probes use light to perturb cancerous tissue, and then sound detection tools transmit the vibrations. Smart probes are being explored to detect a variety of metaloproteases on the surface of cancer cells, breaking apart and entering cancer cells where they can be detected with an ultrasound probe.

Systems biology approaches to cancer
Similar to aging research, some of the most promising progress points in cancer research are due to a more systemic understanding of disease, and the increasing ability to use tools like gene expression analysis to trace processes across time. One example is being able to identify and model not just one, but whole collections of genes that may be expressed differentially in cancers, seeing that whole pathways are disrupted, and the downstream implications of this.

Cancer causality
Also as in aging research, the 'chicken or the egg' problem arises as multiple things that go wrong are identified, but which happens first, and causality, is still unknown. For example, in ovarian cancer, where there are often mutations in the p53 gene, and gene rearrangements and CNV (copy number variation; different numbers of copies of certain genes), but which occurs first and what causes both is unknown.

Predictive disease modeling
There continues to be a need for models that predict clinical outcome, and serve as accurate representations of disease. DNA and gene expression, integrated with traits and other phenotypic data in global coherent datasets could allow the ability to build probabilistic causal models of disease. It also may be appropriate to shift to physics/accelerator-type models to manage the scale of data now being generated and reviewed in biomedicine.

Monday, May 24, 2010

Human-data interface

There is starting to be more data than ever available to individuals, including personal data, every detail of interactions, activities, behaviors, and health habits tracked. Some contend that humans are not ready to interact with massive data and that a common response is to ignore it. However, humans quickly adapt to most situations and this is the likely course with big data interaction.

Data is likely to only become more pervasive and intimate, and extraordinarily useful to those who can harness it.

There is a structural factor with data collection that could be masking the value of the information – timeframes and scale. Data is collected on daily or hourly timeframes, but may be most useful 1) being dormant, a reserve reference with which to compare when anomalies arise, and 2) longitudinally, reflecting attributes over long time scales; seeing a change in sleep patterns over decades for example. Another example is that while it might seem useless to record one's temperature every day, knowing the average temperatures and heart rates of individuals in a community and any deltas (changes) could be quite useful in predicting the spread and magnitude of pandemics such as H1N1.

Sunday, May 16, 2010

Unified health data climate

The future of health management and biosecurity is having always-on access to the health data climate of individuals, families, communities, and countries. A whole new era of health awareness and self-management could be possible. Ideally, health data streams would be automatically captured and parsed into a comprehensive tableau of status monitoring and action-taking.

Key health data streams (Figure 1):

  1. Genome - whole human genome sequence, abnormal tissue sequences (cancer, etc.)
  2. Phenotype - current status of a wide range of biophysical markers including blood-based organ-secreted proteins prognosticating disease, cholesterol levels, blood pressure, and emotional state
  3. Diseasome - catalog of cumulative immune system exposures and predicted response to toxins
  4. Microbiome - microflora bacteria profile (gut, genital, skin, oral, etc.)
  5. Environmentome - external environment measures including air and water quality, pollen/allergens count

Figure 1: Key health data streams.